Loading...
Keywords
Last Name
Institution

Rose N. Gelineau-Morel, MD

TitleProgram Director, Child Neurology Residency Program
InstitutionChildren's Mercy Kansas City
DepartmentPediatrics
Address2401 Gillham Road
Kansas City MO 64108
ORCID ORCID Icon0000-0002-7387-9082 Additional info
vCardDownload vCard
    Other Positions
    TitlePhysician
    InstitutionChildren's Mercy Kansas City
    DepartmentPediatrics

    TitleClinical Assistant Professor
    InstitutionUniversity of Missouri-Kansas City
    DepartmentNeurology and Pediatrics

    TitleClinical Assistant Professor
    InstitutionUniversity of Kansas Medical Center
    DepartmentNeurology and Pediatrics


    Collapse Biography 
    Collapse education and training
    University of Texas at Austin, Austin, TexasBS/BA06/2007Neurobiology, Plan II Honors Program
    Baylor College of Medicine, Houston, TexasMD05/2012Medicine
    University of Oxford, United Kingdom06/2010Neuroimaging
    Cincinnati Children's Hospital, Cincinnati, OH09/2017Pediatric Neurology Residency
    Children's Mercy Hospital, Kansas City, MO09/2023T32 Pediatric Clinical Pharmacology Fellowship

    Collapse Overview 

    Collapse Research 
    Collapse research overview
    Dr. Gelineau-Morel's research program is on precision therapeutics for children with acquired dystonia and cerebral palsy. Her program focuses on the development of prognostic and predictive biomarkers to facilitate early diagnosis and implementation of an effective, individualized intervention to maximize function and long-term outcomes. The neuroimaging arm investigates structural and functional MRI as a prognostic biomarker to identify infants at risk for the development of acquired dystonia. The clinical pharmacology arm investigates individual pharmacogenomic variability and impact on systemic exposure to trihexyphenidyl, a medication that targets the underlying pathophysiology of acquired dystonia.
    Collapse research activities and funding
    T32HD069038     (ABDEL-RAHMAN, SUSAN M)May 1, 2011 - Mar 31, 2026
    NIH
    Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology
    Role: Fellow

    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cohen ASA, Farrow EG, Abdelmoity AT, Alaimo JT, Amudhavalli SM, Anderson JT, Bansal L, Bartik L, Baybayan P, Belden B, Berrios CD, Biswell RL, Buczkowicz P, Buske O, Chakraborty S, Cheung WA, Coffman KA, Cooper AM, Cross LA, Curran T, Dang TTT, Elfrink MM, Engleman KL, Fecske ED, Fieser C, Fitzgerald K, Fleming EA, Gadea RN, Gannon JL, Gelineau-Morel RN, Gibson M, Goldstein J, Grundberg E, Halpin K, Harvey BS, Heese BA, Hein W, Herd SM, Hughes SS, Ilyas M, Jacobson J, Jenkins JL, Jiang S, Johnston JJ, Keeler K, Korlach J, Kussmann J, Lambert C, Lawson C, Le Pichon JB, Leeder JS, Little VC, Louiselle DA, Lypka M, McDonald BD, Miller N, Modrcin A, Nair A, Neal SH, Oermann CM, Pacicca DM, Pawar K, Posey NL, Price N, Puckett LMB, Quezada JF, Raje N, Rowell WJ, Rush ET, Sampath V, Saunders CJ, Schwager C, Schwend RM, Shaffer E, Smail C, Soden S, Strenk ME, Sullivan BR, Sweeney BR, Tam-Williams JB, Walter AM, Welsh H, Wenger AM, Willig LK, Yan Y, Younger ST, Zhou D, Zion TN, Thiffault I, Pastinen T. Genomic answers for children: Dynamic analyses of >1000 pediatric rare disease genomes. Genet Med. 2022 06; 24(6):1336-1348. PMID: 35305867.
      View in: PubMed
    2. Sabapathy T, Bansal R, Bojorquez L, Salley B, Gianakon JG, Gelineau-Morel R, Nyp SS. Missed Opportunities and the Impact of the Pandemic. J Dev Behav Pediatr. 2022 04 01; 43(3):176-179. PMID: 35085180.
      View in: PubMed
    3. Wilson JL, Kim YM, O'Malley JA, Gelineau-Morel R, Gilbert L, Bain JM, Aravamuthan BR. Cerebral Palsy in Child Neurology and Neurodevelopmental Disabilities Training: An Unmet Need. J Child Neurol. 2022 03; 37(3):194-201. PMID: 35037781.
      View in: PubMed
    4. Gelineau-Morel R. Rose Gelineau-Morel, MD: Early Career Investigator-March 2022. Pediatr Res. 2022 03; 91(4):724. PMID: 34937874.
      View in: PubMed
    5. Dasari VR, Shapiro SM, Yeh HW, Gelineau-Morel R. Kernicterus Spectrum Disorders Diagnostic Toolkit: validation using retrospective chart review. Pediatr Res. 2022 03; 91(4):862-866. PMID: 34741107.
      View in: PubMed
    6. Domino JS, Gelineau-Morel R, Kaufman C. Deep Brain Stimulation for Cockayne Syndrome-Associated Movement Disorder. J Mov Disord. 2022 Jan; 15(1):62-65. PMID: 34724781.
      View in: PubMed
    7. Gelineau-Morel R, Dilts J. Virtual Education During COVID-19 and Beyond. Pediatr Neurol. 2021 06; 119:1-2. PMID: 33812265.
      View in: PubMed
    8. Ng A, Galosi S, Salz L, Wong T, Schwager C, Amudhavalli S, Gelineau-Morel R, Chowdhury S, Friedman J. Failure to thrive - an overlooked manifestation of KMT2B-related dystonia: a case presentation. BMC Neurol. 2020 Jun 16; 20(1):246. PMID: 32546208.
      View in: PubMed
    9. Gelineau-Morel RN, Zinkus TP, Le Pichon JB. Pediatric Head Trauma: A Review and Update. Pediatr Rev. 2019 Sep; 40(9):468-481. PMID: 31477589.
      View in: PubMed
    10. Gelineau-Morel R, Lukacs M, Weaver KN, Hufnagel RB, Gilbert DL, Stottmann RW. Congenital Cataracts and Gut Dysmotility in a DYNC1H1 Dyneinopathy Patient. Genes (Basel). 2016 Oct 14; 7(10). PMID: 27754416.
      View in: PubMed
    11. Vannest J, Tenney JR, Gelineau-Morel R, Maloney T, Glauser TA. Cognitive and behavioral outcomes in benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav. 2015 Apr; 45:85-91. PMID: 25775975.
      View in: PubMed
    12. Arun T, Tomassini V, Sbardella E, de Ruiter MB, Matthews L, Leite MI, Gelineau-Morel R, Cavey A, Vergo S, Craner M, Fugger L, Rovira A, Jenkinson M, Palace J. Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Brain. 2013 Jan; 136(Pt 1):106-15. PMID: 23365093.
      View in: PubMed
    13. Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp. 2012 Dec; 33(12):2802-14. PMID: 21976406.
      View in: PubMed
    14. Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord. 2010 Oct 15; 25(13):2171-5. PMID: 20690167.
      View in: PubMed
    15. Cummings ME, Gelineau-Kattner R. The energetic costs of alternative male reproductive strategies in Xiphophorus nigrensis. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2009 Oct; 195(10):935-46. PMID: 19688216.
      View in: PubMed
    Gelineau-Morel's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description